NOI -Illumina Infinium Methylation Screening Array
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to award a firm-fixed-price purchase order on a non-competitive basis to Illumina, Inc. for twenty (20) Infinium Methylation Screening Array-48 Kits. This procurement supports the NHLBI Division of Intramural Research, Laboratory of Genomic Instability and Cardiopulmonary Outcomes (LoGICO) for an epigenome-wide association study (EWAS). Quotations are due June 18, 2026, at 9:00 AM EDT.
Scope of Work
This requirement is for twenty (20) Illumina Infinium Methylation Screening Array-48 Kits (Catalog No. 20112611). These kits are essential for conducting an epigenome-wide association study of DNA methylation patterns and cardiovascular disease (CVD) mortality risk, utilizing biospecimens from the NCI PLCO Cancer Screening Trial. The kits must interrogate approximately 270,000 CpG methylation sites, require 50 ng genomic DNA input per sample, and be compatible with the existing Illumina iScan System and Infinium Automated Pipetting System with ILASS at the NIA Laboratory of Neurogenetics.
Contract Details
- Contract Type: Firm-Fixed-Price Purchase Order
- Period of Performance: June 19, 2026, to December 31, 2026
- Delivery: By December 31, 2026, FOB Destination, at NIH NIA Laboratory of Neurogenetics, Bethesda, MD
- NAICS Code: 325413 – In-Vitro Diagnostic Substance Manufacturing
- Size Standard: 1,250 employees
- Set-Aside: This requirement is not set aside for small business.
Submission & Evaluation
- Submission Deadline: June 18, 2026, 9:00 AM EDT
- Submission Method: Electronically to nicholas.capobianco@nih.gov
- Required Information: Quotations must include unit price, list price, shipping/handling, delivery timeframe, prompt payment discount terms, F.O.B. point, product/catalog numbers, product descriptions, UEI, TIN, and business size certification. Offerors must be registered in SAM.gov.
- Evaluation: Award will be made to the responsible offeror whose quotation conforms to requirements and represents the best value to the Government, considering price and demonstrated ability to furnish the brand-name product or an item meeting salient characteristics.
Additional Notes
This is a non-competitive solicitation, as Illumina, Inc. is identified as the sole manufacturer and source of the proprietary Infinium Methylation Screening Array, which is protected by patents and trade secrets and is the only compatible product with existing NIH equipment. Offerors claiming to be manufacturers or authorized resellers must provide specific documentation.